Senile Cataract (Age-Related Cataract) Questions & Answers

1. Congdon N, Vingerling JR, Klein BE, West S, Friedman DS, Kempen J, et al. Prevalence of cataract and pseudophakia/aphakia among adults in the United States. Arch Ophthalmol. 2004 Apr. 122(4):487-94. [QxMD MEDLINE Link].

2. You QS, Xu L, Yang H, Wang YX, Jonas JB. Five-Year Incidence of Visual Impairment and Blindness in Adult Chinese The Beijing Eye Study. Ophthalmology. 2011 Jan 4. [QxMD MEDLINE Link].

3. Liang YB, Friedman DS, Wong TY, Zhan SY, Sun LP, Wang JJ. Prevalence and causes of low vision and blindness in a rural chinese adult population: the Handan Eye Study. Ophthalmology. 2008 Nov. 115(11):1965-72. [QxMD MEDLINE Link].

4. Maberley DA, Hollands H. The prevalence of low vision and blindness in Canada. Eye(Lond). 2006/03. 20(3):341-6.

5. Iwase A, Araie M, Tomidokoro A, Yamamoto T, Shimizu H, Kitazawa Y. Prevalence and causes of low vision and blindness in a Japanese adult population: the Tajimi Study. Ophthalmology. 2006 Aug. 113(8):1354-62. [QxMD MEDLINE Link].

6. Buch H, Vinding T, Nielsen NV. Prevalence and causes of visual impairment according to World Health Organization and United States criteria in an aged, urban Scandinavian population: the Copenhagen City Eye Study. Ophthalmology. 2001 Dec. 108(12):2347-57. [QxMD MEDLINE Link].

7. Limburg H, Barria von-Bischhoffshausen F, Gomez P, Silva JC, Foster A. Review of recent surveys on blindness and visual impairment in Latin America. Br J Ophthalmol. 2008 Mar. 92(3):315-9. [QxMD MEDLINE Link].

8. Murthy GV, Vashist P, John N, Pokharel G, Ellwein LB. Prevelence and causes of visual impairment and blindness in older adults in an area of India with a high cataract surgical rate. Ophthalmic Epidemiol. 2010 Aug. 17(4):185-95. [QxMD MEDLINE Link].

9. Meddings DR, Marion SA, Barer ML, Evans RG, Green B, Hertzman C, et al. Mortality rates after cataract extraction. Epidemiology. 1999 May. 10(3):288-93. [QxMD MEDLINE Link].

10. Hirsch RP, Schwartz B. Increased mortality among elderly patients undergoing cataract extraction. Arch Ophthalmol. 1983 Jul. 101(7):1034-7. [QxMD MEDLINE Link].

11. Sperduto RD, Hiller R. The prevalence of nuclear, cortical, and posterior subcapsular lens opacities in a general population sample. Ophthalmology. 1984 Jul. 91(7):815-8. [QxMD MEDLINE Link].

12. Nishikiori T, Yamamoto K. Epidemiology of cataracts. Dev Ophthalmol. 1987. 15:24-7. [QxMD MEDLINE Link].

13. Martinez GS, Campbell AJ, Reinken J, Allan BC. Prevalence of ocular disease in a population study of subjects 65 years old and older. Am J Ophthalmol. 1982 Aug. 94(2):181-9. [QxMD MEDLINE Link].

14. Kulaksızoglu S, Karalezli A. Aqueous Humour and Serum Levels of Nitric Oxide, Malondialdehyde and Total Antioxidant Status in Patients with Type 2 Diabetes with Proliferative Diabetic Retinopathy and Nondiabetic Senile Cataracts. Can J Diabetes. 2015 Sep 18. [QxMD MEDLINE Link].

15. Yousefi R, Javadi S, Amirghofran S, Oryan A, Moosavi-Movahedi AA. Assessment of structure, stability and aggregation of soluble lens proteins and alpha-crystallin upon non-enzymatic glycation: The pathomechanisms underlying cataract development in diabetic patients. Int J Biol Macromol. 2015 Oct 23. [QxMD MEDLINE Link].

16. West SK, Valmadrid CT. Epidemiology of risk factors for age-related cataract. Surv Ophthalmol. 1995 Jan-Feb. 39(4):323-34. [QxMD MEDLINE Link].

17. Miglior S, Marighi PE, Musicco M, Balestreri C, Nicolosi A, Orzalesi N. Risk factors for cortical, nuclear, posterior subcapsular and mixed cataract: a case-control study. Ophthalmic Epidemiol. 1994 Jun. 1(2):93-105. [QxMD MEDLINE Link].

18. Richter GM, Choudhury F, Torres M, Azen SP, Varma R. Risk factors for incident cortical, nuclear, posterior subcapsular, and mixed lens opacities: the Los Angeles Latino eye study. Ophthalmology. 2012 Oct. 119(10):2040-7. [QxMD MEDLINE Link]. [Full Text].

19. Johns KJ, Feder RS, Rosenfeld SI, et al. Lens and cataract. American Academy of Ophthalmology Basic and Clinical Science Course. 1999-2000. Vol. 11.:

20. Al-Ghadyan AA, Cotlier E. Rise in lens temperature on exposure to sunlight or high ambient temperature. Br J Ophthalmol. 1986 Jun. 70(6):421-6. [QxMD MEDLINE Link].

21. Kanthan GL, Mitchell P, Burlutsky G, Rochtchina E, Wang JJ. Pseudoexfoliation syndrome and the long-term incidence of cataract and cataract surgery: the blue mountains eye study. Am J Ophthalmol. 2013 Jan. 155(1):83-88.e1. [QxMD MEDLINE Link].

22. Costello MJ, Oliver TN, Cobo LM. Cellular architecture in age-related human nuclear cataracts. Invest Ophthalmol Vis Sci. 1992 Oct. 33(11):3209-27. [QxMD MEDLINE Link].

23. Van den Bruel A, Gailly J, Devriese S, Welton NJ, Shortt AJ, Vrijens F. The protective effect of ophthalmic viscoelastic devices on endothelial cell loss during cataract surgery: a meta-analysis using mixed treatment comparisons. Br J Ophthalmol. 2011 Jan. 95(1):5-10. [QxMD MEDLINE Link].

24. Lundström M, Barry P, Henry Y, et al. Visual outcome of cataract surgery; study from the European Registry of Quality Outcomes for Cataract and Refractive Surgery. J Cataract Refract Surg. 2013 May. 39(5):673-9. [QxMD MEDLINE Link].

25. Pullen LC. Ocular Comorbidity Predicts Poor Cataract Surgery Outcomes. Medscape Medical News. May 1 2013. [Full Text].

26. Zhao LQ, Zhu H, Zhao PQ, Wu QR, Hu YQ. Topical Anesthesia versus Regional Anesthesia for Cataract Surgery: A Meta-Analysis of Randomized Controlled Trials. Ophthalmology. 2012 Feb 22. [QxMD MEDLINE Link].

27. Douglas D. Cataract Surgery in Both Eyes May Boost Benefits. Medscape. Feb 4 2013. Available at http://www.medscape.com/viewarticle/778757. Accessed: Apr 17 2013.

28. Lee BS, Munoz BE, West SK, Gower EW. Functional Improvement after One- and Two-Eye Cataract Surgery in the Salisbury Eye Evaluation. Ophthalmology. 2013 Jan 25. [QxMD MEDLINE Link].

29. Laidman J. Alfuzosin for BPH linked to fewer snags in cataract surgery. Medscape Medical News. February 13, 2014. [Full Text].

30. Chang DF, Campbell JR, Colin J, Schweitzer C. Prospective Masked Comparison of Intraoperative Floppy Iris Syndrome Severity with Tamsulosin versus Alfuzosin. Ophthalmology. 2013 Dec 4. [QxMD MEDLINE Link].

31. Bell CM, Hatch WV, Fischer HD, Cernat G, Paterson M, Gruneir A, et al. Association between tamsulosin and serious ophthalmic adverse events in older men following cataract surgery. JAMA. 2009 May 20. 301(19):1991-6. [Full Text].

32. Baker PS, Spirn MJ, Chiang A, et al. 23-Gauge transconjunctival pars plana vitrectomy for removal of retained lens fragments. Am J Ophthalmol. 2011 Oct. 152(4):624-7. [QxMD MEDLINE Link].

33. Klein BE, Howard KP, Lee KE, Iyengar SK, Sivakumaran TA, Klein R. The Relationship of Cataract and Cataract Extraction to Age-related Macular Degeneration: The Beaver Dam Eye Study. Ophthalmology. 2012 Aug. 119(8):1628-33. [QxMD MEDLINE Link]. [Full Text].

34. Calladine D, Evans JR, Shah S, Leyland M. Multifocal versus monofocal intraocular lenses after cataract extraction. Cochrane Database Syst Rev. 2012 Sep 12. 9:CD003169. [QxMD MEDLINE Link].

35. Lewis R. FDA Approves Tecnis Toric Intraocular Lens. Medscape Medical News. Available at http://www.medscape.com/viewarticle/782778. Accessed: May 2, 2013.

36. Brooks M. FDA OKs First Gel Sealant for Use in Cataract Surgery. Medscape [serial online]. Available at http://www.medscape.com/viewarticle/818977. Accessed: January 20, 2014.

37. Asano S, Miyake K, Ota I, Sugita G, Kimura W, Sakka Y, et al. Reducing angiographic cystoid macular edema and blood-aqueous barrier disruption after small-incision phacoemulsification and foldable intraocular lens implantation: multicenter prospective randomized comparison of topical diclofenac 0.1% and betamethasone 0.1%. J Cataract Refract Surg. 2008 Jan. 34(1):57-63. [QxMD MEDLINE Link].

38. Szijarto Z, Schvoller M, Poto L, Kuhn F, Kovacs B. Pseudophakic retinal detachment after phacoemulsification. Ann Ophthalmol (Skokie). 2007 Jun. 39(2):134-9. [QxMD MEDLINE Link].

39. Cao X, Liu A, Zhang J, Li Y, Jie Y, Liu W, et al. Clinical analysis of endophthalmitis after phacoemulsification. Can J Ophthalmol. 2007 Dec. 42(6):844-8. [QxMD MEDLINE Link].

40. Pullen LC. Experimental Plug Aids Recovery From Cataract Surgery. Medscape Medical News. Oct 27 2014. [Full Text].

41. Sarkar S, Mondal KK, Roy SS, Gayen S, Ghosh A, De RR. Comparison of preoperative nepafenac (0.1%) and flurbiprofen (0.03%) eye drops in maintaining mydriasis during small incision cataract surgery in patients with senile cataract: A randomized, double-blind study. Indian J Pharmacol. 2015 Sep-Oct. 47 (5):491-5. [QxMD MEDLINE Link].

42. Rabin SM. Medicolegal concerns of cataract surgeons. Management and Care of the Cataract Patient. 1992. 331-8.

43. Belkin M, Jacobs DR, Jackson SM, Zwick H. Senile cataracts and myopia. Ann Ophthalmol. 1982 Jan. 14(1):49-50. [QxMD MEDLINE Link].

44. Bellows JG, Bellows RT. Crosslinkage theory of senile cataracts. Ann Ophthalmol. 1976 Feb. 8(2):129-35. [QxMD MEDLINE Link].

45. Bilge AH, Aykan U, Akin T, Unsal U. Review of sterile, postoperative, anterior segment inflammation following cataract extraction and intraocular lens implantation. Eur J Ophthalmol. 2005 Mar-Apr. 15(2):224-7. [QxMD MEDLINE Link].

46. Bunce GE, Kinoshita J, Horwitz J. Nutritional factors in cataract. Annu Rev Nutr. 1990. 10:233-54. [QxMD MEDLINE Link].

47. Burgess CA, Sowers M. Systemic hypertension and senile cataracts: an epidemiologic study. Optom Vis Sci. 1992 Apr. 69(4):320-4. [QxMD MEDLINE Link].

48. Cataracts continue to be leading cause of vision loss and blindness in the United States. Prevent Blindness America. Available at http://www.preventblindness.org/.

49. Charakidas A, Kalogeraki A, Tsilimbaris M, Koukoulomatis P, Brouzas D, Delides G. Lens epithelial apoptosis and cell proliferation in human age-related cortical cataract. Eur J Ophthalmol. 2005 Mar-Apr. 15(2):213-20. [QxMD MEDLINE Link].

50. Chatterjee A, Milton RC, Thyle S. Prevalence and aetiology of cataract in Punjab. Br J Ophthalmol. 1982 Jan. 66(1):35-42. [QxMD MEDLINE Link].

51. Chylack LT Jr. Mechanisms of senile cataract formation. Ophthalmology. 1984 Jun. 91(6):596-602. [QxMD MEDLINE Link].

52. Eckerskorn U, Hockwin O, Muller-Breitenkamp R, Chen TT, Knowles W, Dobbs RE. Evaluation of cataract-related risk factors using detailed classification systems and multivariate statistical methods. Dev Ophthalmol. 1987. 15:82-91. [QxMD MEDLINE Link].

53. Emery JM, Wilhelmus KA, Rosenberg S. Complications of phacoemulsification. Ophthalmology. 1978 Feb. 85(2):141-50. [QxMD MEDLINE Link].

54. Fujiwara H, Takigawa Y, Suzuki T, Nakata K. Superoxide dismutase activity in cataractous lenses. Jpn J Ophthalmol. 1992. 36(3):273-80. [QxMD MEDLINE Link].

55. Ghafour IM, Allan D, Foulds WS. Common causes of blindness and visual handicap in the west of Scotland. Br J Ophthalmol. 1983 Apr. 67(4):209-13. [QxMD MEDLINE Link].

56. Gibson JM, Rosenthal AR, Lavery J. A study of the prevalence of eye disease in the elderly in an English community. Trans Ophthalmol Soc U K. 1985. 104 (Pt 2):196-203. [QxMD MEDLINE Link].

57. Gibson JM, Shaw DE, Rosenthal AR. Senile cataract and senile macular degeneration: an investigation into possible risk factors. Trans Ophthalmol Soc U K. 1986. 105 (Pt 4):463-8. [QxMD MEDLINE Link].

58. Hirneiss C, Neubauer AS, Kampik A, Schönfeld CL. Comparison of prednisolone 1%, rimexolone 1% and ketorolac tromethamine 0.5% after cataract extraction: a prospective, randomized, double-masked study. Graefes Arch Clin Exp Ophthalmol. 2005 Aug. 243(8):768-73. [QxMD MEDLINE Link].

59. Hollows F, Moran D. Cataract--the ultraviolet risk factor. Lancet. 1981 Dec 5. 2(8258):1249-50. [QxMD MEDLINE Link].

60. Hu TS, Lao YX. An epidemiologic survey of senile cataract in China. Dev Ophthalmol. 1987. 15:42-51. [QxMD MEDLINE Link].

61. Imbach P, Odavic R, Bleher EA, Bucher U, Deubelbeiss KA, Wagner HP. [Autologous bone marrow reimplantation in children with advanced tumor. First experiences of feasibility]. Schweiz Med Wochenschr. 1979 Feb 24. 109(8):283-7. [QxMD MEDLINE Link].

62. Jacques PF, Chylack LT Jr, McGandy RB, Hartz SC. Antioxidant status in persons with and without senile cataract. Arch Ophthalmol. 1988 Mar. 106(3):337-40. [QxMD MEDLINE Link].

63. Javitt JC, Taylor HR. Cataract and latitude. Doc Ophthalmol. 1994-1995. 88(3-4):307-25. [QxMD MEDLINE Link].

64. Kador PF. Overview of the current attempts toward the medical treatment of cataract. Ophthalmology. 1983 Apr. 90(4):352-64. [QxMD MEDLINE Link].

65. Kahn HA, Leibowitz HM, Ganley JP, Kini MM, Colton T, Nickerson RS, et al. The Framingham Eye Study. I. Outline and major prevalence findings. Am J Epidemiol. 1977 Jul. 106(1):17-32. [QxMD MEDLINE Link].

66. Kamei A. Characterization of water-insoluble proteins in normal and cataractous human lens. Jpn J Ophthalmol. 1990. 34(2):216-24. [QxMD MEDLINE Link].

67. Kamei A. Glutathione levels of the human crystalline lens in aging and its antioxidant effect against the oxidation of lens proteins. Biol Pharm Bull. 1993 Sep. 16(9):870-5. [QxMD MEDLINE Link].

68. Katoh N, Sasaki K, Shibata T, Obazawa H, Fujiwara T, Kogure F, et al. Case-control study of senile cataract in Japan: a preliminary report. Jpn J Ophthalmol. 1993. 37(4):467-77. [QxMD MEDLINE Link].

69. Ke Y, Jiang J, Chen P, Weng Y, Yang Y. Phacoemulsification and posterior chamber intraocular lens implantation. Zhonghua Yan Ke Za Zhi. 1996 Mar. 32(2):85-91. [QxMD MEDLINE Link].

70. Kini MM, Leibowitz HM, Colton T, Nickerson RJ, Ganley J, Dawber TR. Prevalence of senile cataract, diabetic retinopathy, senile macular degeneration, and open-angle glaucoma in the Framingham eye study. Am J Ophthalmol. 1978 Jan. 85(1):28-34. [QxMD MEDLINE Link].

71. Knekt P, Heliövaara M, Rissanen A, Aromaa A, Aaran RK. Serum antioxidant vitamins and risk of cataract. BMJ. 1992 Dec 5. 305(6866):1392-4. [QxMD MEDLINE Link].

72. Lee SM, Lin SY, Li MJ, Liang RC. Possible mechanism of exacerbating cataract formation in cataractous human lens capsules induced by systemic hypertension or glaucoma. Ophthalmic Res. 1997. 29(2):83-90. [QxMD MEDLINE Link].

73. Lu M, Taylor A, Chylack LT Jr, Rogers G, Hankinson SE, Willett WC, et al. Dietary fat intake and early age-related lens opacities. Am J Clin Nutr. 2005 Apr. 81(4):773-9. [QxMD MEDLINE Link].

74. Lydahl E. Infrared radiation and cataract. Acta Ophthalmol Suppl. 1984. 166:1-63. [QxMD MEDLINE Link].

75. Moffat BA, Landman KA, Truscott RJ, Sweeney MH, Pope JM. Age-related changes in the kinetics of water transport in normal human lenses. Exp Eye Res. 1999 Dec. 69(6):663-9. [QxMD MEDLINE Link].

76. Mozaffarieh M, Heinzl H, Sacu S, Wedrich A. Clinical outcomes of phacoemulsification cataract surgery in diabetes patients: visual function (VF-14), visual acuity and patient satisfaction. Acta Ophthalmol Scand. 2005 Apr. 83(2):176-83. [QxMD MEDLINE Link].

77. Packer M, Fishkind WJ, Fine IH, Seibel BS, Hoffman RS. The physics of phaco: a review. J Cataract Refract Surg. 2005 Feb. 31(2):424-31. [QxMD MEDLINE Link].

78. Papamatheakis DG, Demers P, Vachon A, Jaimes LB, Lapointe Y, Harasymowycz PJ. Thrombocytopenia and the risks of intraocular surgery. Ophthalmic Surg Lasers Imaging. 2005 Mar-Apr. 36(2):103-7. [QxMD MEDLINE Link].

79. Recchia FM, Busbee BG, Pearlman RB, Carvalho-Recchia CA, Ho AC. Changing trends in the microbiologic aspects of postcataract endophthalmitis. Arch Ophthalmol. 2005 Mar. 123(3):341-6. [QxMD MEDLINE Link].

80. Robertson JM, Donner AP, Trevithick JR. A possible role for vitamins C and E in cataract prevention. Am J Clin Nutr. 1991 Jan. 53(1 Suppl):346S-351S. [QxMD MEDLINE Link].

81. Sack R, Cohen J. Comparative diets of a idiopathic senile cataract and normal population: dietary risk factors in cataractogenesis. Metab Pediatr Syst Ophthalmol. 1987. 10(1):9-13. [QxMD MEDLINE Link].

82. Shaikh MR, Janjua MZ. Morphological and morphometrical study of human lens in senile cataract. J Pak Med Assoc. 1997 May. 47(5):141-4. [QxMD MEDLINE Link].

83. Sharma YR, Vajpayee RB, Honavar SG. Sunlight and cortical cataract. Arch Environ Health. 1994 Sep-Oct. 49(5):414-7. [QxMD MEDLINE Link].

84. Sommer A. Cataracts as an epidemiologic problem. Am J Ophthalmol. 1977 Mar. 83(3):334-9. [QxMD MEDLINE Link].

85. Sommer A, Tielsch JM, Katz J, Quigley HA, Gottsch JD, Javitt JC, et al. Racial differences in the cause-specific prevalence of blindness in east Baltimore. N Engl J Med. 1991 Nov 14. 325(20):1412-7. [QxMD MEDLINE Link].

86. Steinkuller PG. Cataract: the leading cause of blindness and vision loss in Africa. Soc Sci Med. 1983. 17(22):1693-702. [QxMD MEDLINE Link].

87. Street DA, Javitt JC. National five-year mortality after inpatient cataract extraction. Am J Ophthalmol. 1992 Mar 15. 113(3):263-8. [QxMD MEDLINE Link].

88. Tseng SH, Tang MJ. Na,K-ATPase in lens epithelia from patients with senile cataracts. J Formos Med Assoc. 1999 Sep. 98(9):627-32. [QxMD MEDLINE Link].

89. Tseng SH, Yen JS, Chien HL. Lens epithelium in senile cataract. J Formos Med Assoc. 1994 Feb. 93(2):93-8. [QxMD MEDLINE Link].

90. Worgul BV, Merriam GR Jr, Medvedovsky C. Cortical cataract development--an expression of primary damage to the lens epithelium. Lens Eye Toxic Res. 1989. 6(4):559-71. [QxMD MEDLINE Link].

91. Wu TT, Amini L, Leffler CT, Schwartz SG. Cataracts and cataract surgery in mentally retarded adults. Eye Contact Lens. 2005 Mar. 31(2):50-3. [QxMD MEDLINE Link].

Vicente Victor Dizon Ocampo, Jr, MD Chair, Department of Ophthalmology, Head, Uveitis and Ocular Immunology Service, Ospital ng Makati, Philippines; Vice-Chair, Department of Ophthalmology, Asian Hospital and Medical Center, Philippines; President, Philippine Ocular Inflammation Society

Vicente Victor Dizon Ocampo, Jr, MD is a member of the following medical societies: International Ocular Inflammation Society, Philippine Academy of Ophthalmology, Philippine Ocular Inflammation Society

Disclosure: Nothing to disclose.

C Stephen Foster, MD, FACS, FACR, FAAO, FARVO Clinical Professor of Ophthalmology, Harvard Medical School; Consulting Staff, Department of Ophthalmology, Massachusetts Eye and Ear Infirmary; Founder and President, Ocular Immunology and Uveitis Foundation, Massachusetts Eye Research and Surgery Institution

C Stephen Foster, MD, FACS, FACR, FAAO, FARVO is a member of the following medical societies: Alpha Omega Alpha, American Academy of Ophthalmology, American Association of Immunologists, American College of Rheumatology, American College of Surgeons, American Federation for Clinical Research, American Medical Association, American Society for Microbiology, American Uveitis Society, Association for Research in Vision and Ophthalmology, Massachusetts Medical Society, Royal Society of Medicine, Sigma Xi, The Scientific Research Honor Society

Disclosure: Serve(d) as a director, officer, partner, employee, advisor, consultant or trustee for: Aldeyra Therapeutics (Lexington, MA); Bausch & Lomb Surgical, Inc (Rancho Cucamonga, CA); Eyegate Pharma (Waltham, MA); Novartis (Cambridge, MA); pSivida (Watertown, MA); Xoma (Berkeley, CA); Allakos (Redwood City, CA)<br/>Serve(d) as a speaker or a member of a speakers bureau for: Alcon (Geneva, Switzerland); Allergan (Dublin, Ireland); Mallinckrodt (Staines-upon-Thames, United Kingdom)<br/>Received research grant from: Alcon; Aldeyra Therapeutics; Allakos Pharmaceuticals; Allergan; Bausch & Lomb; Clearside Biomedical; Dompé pharmaceutical; Eyegate Pharma; Mallinckrodt pharmaceuticals; Novartis; pSivida; Santen; Aciont<br/>Stock for: Eyegate Pharma.

Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Received salary from Medscape for employment. for: Medscape.

J James Rowsey, MD Former Director of Corneal Services, St Luke's Cataract and Laser Institute

J James Rowsey, MD is a member of the following medical societies: American Academy of Ophthalmology, American Association for the Advancement of Science, American Medical Association, Association for Research in Vision and Ophthalmology, Florida Medical Association, Sigma Xi, The Scientific Research Honor Society, Southern Medical Association, Pan-American Association of Ophthalmology

Disclosure: Nothing to disclose.

Andrew A Dahl, MD, FACS Assistant Professor of Surgery (Ophthalmology), New York College of Medicine (NYCOM); Director of Residency Ophthalmology Training, The Institute for Family Health and Mid-Hudson Family Practice Residency Program; Staff Ophthalmologist, Telluride Medical Center

Andrew A Dahl, MD, FACS is a member of the following medical societies: American Academy of Ophthalmology, American College of Surgeons, American Intraocular Lens Society, American Medical Association, American Society of Cataract and Refractive Surgery, Contact Lens Association of Ophthalmologists, Medical Society of the State of New York, New York State Ophthalmological Society, Outpatient Ophthalmic Surgery Society

Disclosure: Nothing to disclose.

Richard W Allinson, MD Associate Professor, Department of Ophthalmology, Texas A&M University Health Science Center; Senior Staff Ophthalmologist, Scott and White Clinic

Richard W Allinson, MD is a member of the following medical societies: American Academy of Ophthalmology, American Medical Association, Texas Medical Association

Disclosure: Nothing to disclose.

• Print this section
• Print the entire contents of
• Print the entire contents of article